Document Detail

Attitudinal survey of voluntary reporting of adverse drug reactions.
MedLine Citation:
PMID:  10583035     Owner:  NLM     Status:  MEDLINE    
AIMS: Voluntary adverse drug reaction (ADR) reporting schemes have operated since the early sixties in many Western countries. It is generally recognized, however, that only a small proportion of ADRs is actually reported. The current survey was conducted to assess attitudes towards reporting of ADRs, and to study which types of ADRs are reported. METHODS: A questionnaire seeking reasons for nonreporting was sent to a random sample of 10% of medical practitioners in The Netherlands in October 1997. After 6 weeks, a reminder was sent to those who had not responded. RESULTS: One thousand four hundred and forty-two (73%) questionnaires were returned, of which 94% were complete. The percentage of GPs (51%) which had ever reported an ADR to the national reporting centre was significantly higher than the percentage of specialists (35%), who reported more often to the pharmaceutical industry (34% vs 48%). 86% of GPs, 72% of surgical specialists and 81% of medical specialists had ever diagnosed an ADR, which they had not reported. Uncertainty as to whether the reaction was caused by a drug (72%), the ADR being trivial (75%) or too well known (93%) were the most important reasons for not reporting. 18% were not aware of the need to report ADRs, 22% did not know how to report ADRs, 38% did not have enough time, 36% thought that reporting was too bureaucratic and only 26% of Dutch physicians knew which ADRs to report. A serious ADR, an unlabelled ADR, an ADR to a new drug, history of reporting of one or more ADRs, and specialty were all independently associated with reporting of 16 hypothetical ADRs. Surgical and medical specialists tended to report less often than GPs. CONCLUSIONS: There is a considerable degree of underreporting, which might partly be explained by lack of knowledge and misconceptions about spontaneous reporting of adverse drug reactions.
I A Eland; K J Belton; A C van Grootheest; A P Meiners; M D Rawlins; B H Stricker
Related Documents :
12218245 - Monoclonal rearrangement of the t cell receptor gamma-chain in lichenoid pigmented purp...
8519185 - Honeysuckle contact dermatitis.
12353045 - Adverse reactions associated with the use of eugenol in dentistry.
20181075 - Non-allergic rhinitis: a case report and review.
23258455 - The incidence of decompression illness in 10 years of scientific diving.
14506965 - Applications of monoclonal anti-human inhibin alpha subunit in endometrial curettings.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  48     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1999 Oct 
Date Detail:
Created Date:  1999-12-16     Completed Date:  1999-12-16     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  623-7     Citation Subset:  IM    
Pharmaco-epidemiology Unit, Departments of Internal Medicine and Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adverse Drug Reaction Reporting Systems / standards*
Attitude of Health Personnel*
Data Collection

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of guidelines implemented in a paris university hospital: application to the use of antiemeti...
Next Document:  Persistence of anti-hypertensive effect after missed dose of perindopril.